Correlation Between Neuropace and Xtant Medical

Can any of the company-specific risk be diversified away by investing in both Neuropace and Xtant Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Xtant Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neuropace and Xtant Medical Holdings, you can compare the effects of market volatilities on Neuropace and Xtant Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Xtant Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Xtant Medical.

Diversification Opportunities for Neuropace and Xtant Medical

0.72

Correlation Coefficient

Neuropace  Xtant Medical

Poor diversification

The 3 months correlation between Neuropace and Xtant is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Xtant Medical Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xtant Medical Holdings and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Xtant Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xtant Medical Holdings has no effect on the direction of Neuropace i.e., Neuropace and Xtant Medical go up and down completely randomly.

Pair Corralation between Neuropace and Xtant Medical

Given the investment horizon of 90 days Neuropace is expected to generate 1.28 times less return on investment than Xtant Medical. But when comparing it to its historical volatility, Neuropace is 1.53 times less risky than Xtant Medical. It trades about 0.06 of its potential returns per unit of risk. Xtant Medical Holdings is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  46.00  in Xtant Medical Holdings on December 29, 2024 and sell it today you would earn a total of  3.00  from holding Xtant Medical Holdings or generate 6.52% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Neuropace  vs.  Xtant Medical Holdings

Neuropace

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

Xtant Medical Holdings

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Xtant Medical Holdings are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Xtant Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Neuropace and Xtant Medical

The main advantage of trading using opposite Neuropace and Xtant Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Xtant Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xtant Medical will offset losses from the drop in Xtant Medical's long position.

The idea behind Neuropace and Xtant Medical Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.